Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

caregiving

- PMLiVE

Biogen Idec licenses antisense drugs from Isis in $630m deal

Gains neurological and neuromuscular disorder projects

- PMLiVE

Amgen continues spending spree, acquires deCode Genetics

Will pay $415m for Icelandic genetic information firm

Ronald Berenson to lead Aequus BioPharma

Joins the Cell Therapeutics subsidiary as president and CEO

- PMLiVE

ASH meeting hears of progress with myelofibrosis drugs

New studies suggest momentum is for use of Janus kinase (JAK) inhibitors

- PMLiVE

MHRA streamlines POM-OTC reclassification rules

Aims to speed the process of switching drug status from prescription-only to over-the-counter

- PMLiVE

Eliquis meets targets as long-term VTE therapy

Pfizer and BMS report positive phase III data for the Factor Xa inhibitor

- PMLiVE

Merck KGaA picks Constantin Fest to lead investor relations

He succeeds Joshua Young who will leave the company and move to the US

- PMLiVE

INC Research appoints Robert Ryan

Joins CRO's new Strategic Advisory Services unit

- PMLiVE

Tough times for pharma in Portugal

Industry body warns of paucity of essential medicines and damage to industry reputation

- PMLiVE

EMA: move to greater clinical trial transparency ‘irreversible’

New Europe data rules could be ready by 2014

- PMLiVE

Sanofi picks corporate voice for new blogging venture

Pharma company's US arm goes beyond discussing diabetes

- PMLiVE

AstraZeneca antitrust fine upheld by European Court of Justice

Lessons for pharma as landmark ruling stands

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links